Navigation Links
Parker Waichman LLP Comments on Pending Debut of ‘Sunshine Act,’ Which Will Focus on Cases of Allegedly Fraudulent Financial Links Between Doctors and Manufacturers
Date:7/17/2013

New York, New York (PRWEB) July 17, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs and medical devices, comments on the expected Aug. 1 debut of the Physician Payment Sunshine Act provision of the Affordable Care Act, which is designed to highlight cases of allegedly fraudulent relationships between doctors and pharmaceutical companies and medical device manufacturers, as detailed in the Feb. 8, 2013, Federal Register.

Under the Sunshine Act, all manufacturers of pharmaceuticals, medical devices, and biologicals must report to the National Physician Payment Transparency Program at the Centers for Medicare & Medicaid Services (CMS). These outfits are compelled to report how much money they pay doctors and hospitals, as well as certain information regarding the ownership or investment interests held by physicians or their immediate family members in these companies.

Senate Finance Committee Chairman Max Baucus (D-Mont.) prominently linked the Sunshine Act with a 16-month U.S. Senate investigation that had revealed previously undisclosed ties between Medtronic and some doctors to whom it had paid $210 million to help promote and launch its Infuse bone graft product. The investigation also disclosed that Medtronic employees had collaborated with physician authors to edit, and sometimes write, clinical studies promoting Infuse for publication in medical journals. “These findings emphasize the value of the… Physician Payments Sunshine Act, which will result in public disclosure of industry payments to physicians starting next year,” said Senator Baucus, according to an Oct. 25, 2012, U.S. Senate Finance Committee release.

The Finance Committee had also found problems with most of the initial Medtronic-supported Infuse research, as noted in an Oct. 25, 2012, Bloomberg Businessweek report. The article noted that doctors and researchers had authored at least 11 medical journal reports about Infuse for their multimillion-dollar payment, which was in the form of royalties and consulting fees. Senate investigators also charged that Medtronic deliberately manipulated studies to mitigate any adverse reactions to Infuse side effects, as well as to promote off-label use.

“Ultimately, the public deserves accurate information regarding the benefits and risks associated with any medication or medical device they are considering putting inside their bodies,” said Gary Falkowitz, Managing Attorney from Parker Waichman LLP. “Examples like the Senate’s investigation into the Infuse product show the potential value of the Sunshine Act.”

Parker Waichman LLP is currently offering free legal consultations to victims of Medtronic Infuse Bone Graft Injuries. If you or a loved one suffered a serious complication or injury after receiving Medtronic Infuse, please contact their office by visiting the firm's Medtronic Infuse injury page at yourlawyer.com. Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636).

Contact:     
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
(800) LAW-INFO
(800) 529-4636
http://www.yourlawyer.com

Read the full story at http://www.prweb.com/releases/Sunshine_act_Medtronic/07/prweb10939148.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Plaintiff is Replaced in First Bellwether Trial in DePuy ASR Multidistrict Litigation, Notes Parker Waichman LLP
2. Transvaginal Mesh Multidistrict Litigation Update: Court Chooses Four Bellwether Cases for American Medical Systems, Notes Parker Waichman LLP
3. New Mexico Woman Alleges Mirena IUD Perforated Her Uterus; Parker Waichman LLP Files Lawsuit
4. Da Vinci Surgical Robot Update: FDA Issues Class 2 Recall of Intuitive Surgical’s da Vinci Robot due to Possibly Inadequate Testing of 30 Units, Notes Parker Waichman LLP
5. American Medical Systems’ Transvaginal Mesh Caused Arizona Woman’s Injuries, Alleges Lawsuit Filed by Parker Waichman LLP
6. Actos Caused Bladder Cancer and Wrongful Death of New York Woman, Alleges Lawsuit Filed by Parker Waichman LLP
7. American Medical Systems’ Transvaginal Mesh Allegedly Caused Pennsylvania Woman Severe and Painful Injuries, According to Lawsuit Filed by Parker Waichman LLP
8. Florida Man Develops Bladder Cancer as Result of Taking Actos, Alleges Lawsuit Filed by Parker Waichman LLP
9. Parker Waichman LLP Commends Arkansas Attorney General for Backing Fine Against Johnson & Johnson over Risperdal Off-Label Marketing Allegations
10. Mirena IUD Birth Control Device Perforated Kentucky Woman’s Uterus, Alleges Lawsuit Filed by Parker Waichman LLP
11. Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... Tears® EyeMist®, the signature product of her research center at Bio-Logic Aqua Research® ... largest population and the greatest number of sufferers of blindness. “We think that ...
(Date:7/21/2017)... ... July 21, 2017 , ... In ... researchers from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform ... surgery, though activity levels decline over time. The study, presented today at the ...
(Date:7/21/2017)... ONTARIO, CANADA (PRWEB) , ... July 21, 2017 ... ... give insight into why concussion rates are on the rise, say researchers presenting ... Meeting today in Toronto, Ontario, Canada. , “The combination of evaluating the patterns ...
(Date:7/20/2017)... Va. (PRWEB) , ... July 20, 2017 , ... ... McCarter, MD, has joined JenCare Senior Medical Center as Richmond Chief Medical ... Virginia School of Medicine, and Associate Chief Medical Officer of Ambulatory Services for the ...
(Date:7/20/2017)... (PRWEB) , ... July 20, ... ... provider of enterprise-grade IT operations analytics and application performance monitoring (APM) solutions, ... world’s largest healthcare services providers. , According to Peter Ohrenberger, sales director ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... N.C. , July 10, 2017 Locus ... Convertible Note to support the development of CRISPR-Cas3 antimicrobial ... Holdings Limited, a leading Chinese Internet services provider, and ... will advance multiple infectious disease product programs targeting antibiotic ... Founded by Dr. Rodolphe Barrangou ...
(Date:7/5/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... pharmaceutical company focused on the development of oral drug delivery ... Israel Securities Authority to dual-list its common stock on the ... trading on the TASE on July 12, 2017 under the ... Company, it is expected that Oramed will be included in ...
(Date:7/1/2017)... , June 30, 2017 Zimmer Biomet Holdings, Inc. ... and earnings conference call will be broadcast live over the ... Time.  A news release detailing the quarterly results will be ... the conference call. The live audio webcast can ... http://investor.zimmerbiomet.com . It will be archived for replay following the ...
Breaking Medicine Technology: